The Hongkong Prize presented annually by The Lancet international research journal to researchers for excellence in clinical research is one of the most coveted academic awards in Hong Kong. To qualify, candidates should have published original articles (such as prospective or retrospective clinical studies, observational studies, epidemiological studies, meta-analyses or basic science analyses ) within one year prior to nomination in that journal – reviews articles, letters to editor or case reports will not be considered for consideration for this award.
At an awards ceremony scheduled for November, the winner will be honored with a gold medal and award of HK$1 million. They will also be invited to give a public lecture in Hong Kong as well as additional funding for research in their field of expertise. This award has long been considered one of the most coveted in clinical medicine as it represents excellence in scientific research.
Furthermore, the prize has proven an accurate predictor of Nobel laureates: so far 12 of its 16 winners have gone on to receive this esteemed accolade. This achievement speaks volumes for their hard work and dedication in reaching outstanding achievements within their fields of endeavor.
Hong Kong boasts numerous acclaimed research centres and high-tech expertise, making it a hub for groundbreaking scientific research that benefits society and humanity alike. This fact was recognized when in 2022, the Hong Kong Alliance of Technology and Innovation created the Hongkong Prize thanks to generous support from Bank of China (Hong Kong) Limited.
In addition to offering a monetary award, this prize also seeks to provide incentives for science and technology innovators in Hong Kong to remain and contribute towards its development, while serving humanity. A panel composed of distinguished experts from academia, industry and community administers its selection process with great care.
This year’s winners include a team from Hong Kong Polytechnic University led by Professor Fan Yuan who won for their study of a gene that regulates blood pressure in human kidney models – their findings could assist doctors in diagnosing and treating diseases more accurately.
South China Morning Post team led by senior reporter Edith Lin and news editor Jeffei Lam took home another award, this time for their report on unauthorised structures constructed on luxury properties. Their report beat out competition from both domestic and international news sources to win this accolade.
The Hongkong Prize is given each year to recognize the accomplishments of scientists in Greater China region. It is open to researchers from universities, institutions and enterprises who contribute to science innovation; their pioneering efforts will be recognised for applying research achievements towards community benefit as well as contributing to people of Hong Kong and worldwide society.